Shrinivas Rathod, MD, on NSCLC: Quality-of-Life Outcomes From an IAEA Trial

2017 ASTRO Annual Meeting
Tweet this page

Shrinivas Rathod, MD, of the University of Manitoba, discusses phase III study results on optimization of treatment of advanced non–small cell lung cancer using radiation therapy and chemotherapy (Abstract 223).

Advertisement

Advertisement



Advertisement